Skip to content

A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05857956
Enrollment
40
Registered
2023-05-15
Start date
2023-02-24
Completion date
2023-04-11
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD, Anxiety, Attention Difficulties, Caffeine, Mood

Brief summary

This is a virtual, single-arm clinical trial that will last 28 days. Participants will drink 1 bottle of Proper Wild energy shot daily and complete questionnaires at baseline, day 1, day 14, and day 28. Attention deficit hyperactivity disorder (ADHD)-like symptoms, such as concentration, focus, and attention, will be evaluated at baseline and at each check-in. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Interventions

OTHERProper Wild energy shot

100% plant-based energy shot containing natural caffeine, L-Theanine, purified water, pineapple juice concentrate, natural flavors, kiwi juice concentrate, organic lemon juice concentrate, organic strawberry juice concentrate, monk fruit juice concentrate, pink himalayan sea salt.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Proper Wild, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Currently experiencing symptoms associated with ADHD, including: Impulsiveness. Disorganization and problems prioritizing Poor time management skills Problems focusing on a task Trouble multitasking Excessive activity or restlessness Poor planning * Age 18-55 * Self-reported issues with focus and/or productivity * Generally healthy - don't live with any uncontrolled chronic disease

Exclusion criteria

* Currently taking prescription medication for ADHD * Currently supplementing with L-Theanine. * Known to respond negatively to caffeine (no effect, makes them sleepy or feel unwell) * People with a high caffeine tolerance defined as regular consumption of \>400mg of caffeine (\>4 coffees) per day. * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Anyone with known severe allergic reactions. * Women who are pregnant, breastfeeding, or attempting to become pregnant * Unwilling to follow the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Change in Attention-deficit/hyperactivity disorder (ADHD)-like symptoms. [Time Frame: Baseline to Day 28]28 daysSurvey-based assessment (0-5) scale of changes in symptoms associated with ADHD. Parameters explored include focus & concentration, productivity, mood, and brain fog.

Secondary

MeasureTime frameDescription
Assess the product as a replacement for coffee or caffeinated beverages. [Time Frame: Baseline to Day 28]28 daysSurvey-based assessment regarding changes in daily coffee/beverage consumption, stress, anxiety, jitters, energy crash, and gastrointestinal upset. Responses will be statistically analyzed and reported as % of subject responses.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026